ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NBRV Nabriva Therapeutics PLC

1.42
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 79.41M95.41M89.12M80.91M65.78M54.89M48.24M31.77M
Total Current Assets 78.44M94.62M88.41M80.27M65.2M54.3M47.56M31.1M
Cash and Equivalents 54.79M61.14M52M47.66M33.78M20.04M14.65M12.41M
Total Non-Current Assets 969k789k710k877k581k597k677k941k
Total Liabilities 24.42M26.21M25.83M27.56M21.16M20.29M22.62M28.47M
Total Current Liabilities 18.3M19.21M19.73M22.34M16.27M19.33M21.64M27.61M
Total Non-Current Liabilities 11.3M13.04M11.28M9.48M8.8M1.47M1.38M1.26M
Common Equity 354k497k543k567k617k646k30k32k
Retained Earnings -560.18M-571.93M-582.59M-595.65M-607.47M-618.54M-630.06M-652.83M
Year End December 30 2022 20152016201720182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 117.71M93.24M95.76M110.42M94.11M58.44M80.91M31.77M
Total Current Assets 116.25M90.62M93.84M108.75M91.17M57.22M80.27M31.1M
Cash and Equivalents 36.45M32.78M86.77M102M86.02M41.36M47.66M12.41M
Total Non-Current Assets 108.71M77.26M82.07M68.63M41.27M33.14M53.35M3.29M
Total Liabilities 9.01M15.98M13.7M41.79M52.84M25.3M27.56M28.47M
Total Current Liabilities 8.92M15.88M13.26M17.81M16.64M18.52M22.34M27.61M
Total Non-Current Liabilities 84k107k667k47.7M70.7M12.46M9.48M1.26M
Total Equity 108.71M77.26M82.07M68.63M41.27M33.14M53.35M3.29M
Common Equity 2.41M2.94M367k670k945k211k567k32k
Retained Earnings -167.6M-204.83M-279.17M-393.95M-476.72M-546.2M-595.65M-652.83M

Your Recent History

Delayed Upgrade Clock